目次

1. General Considerations2. Clinical Evaluation and Treatment of Soft Tissue Tumors3. Radiologic Evaluation of Soft Tissue Tumors4. The Molecular Genetic Pathology of Soft Tissue Tumors5. Approach to Diagnosing Soft Tissue Tumors6. Immunohistochemistry for Analysis of Soft Tissue Tumors7. Benign Fibroblastic/Myofibroblastic Proliferations, Including Superficial Fibromatoses8. Fibrous Tumors of Infancy and Childhood9. Borderline and Malignant Fibroblastic/Myofibroblastic Tumors10. Benign Fibrohistiocytic and Histiocytic Tumors11. Fibrohistiocytic Tumors of Intermediate Malignancy12. Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma, and Atypical Fibroxanthoma/Pleomorphic Dermal Sarcoma13. Benign Lipomatous Tumors14. Liposarcoma15. Benign Tumors Showing Smooth Muscle Differentiation16. Benign Genital Stromal Tumors17. Leiomyosarcoma18. GIST and other specialized GI mesenchymal tumors19. Skeletal Muscle Tumors: Benign and of Borderline Malignancy20. Rhabdomyosarcoma21. Benign Vascular Tumors and Malformations22. Hemangioendothelioma: Vascular Tumors of Intermediate Malignancy23. Angiosarcoma, Atypical Vascular Lesions Following Irradiation, and Kaposi Sarcoma24. Tumors and Malformations of Lymphatic Vessels25. Perivascular Tumors26. Benign Tumors and Tumor-like Lesions of Synovial Tissue27. Benign Tumors of Peripheral Nerves28. Malignant Peripheral Nerve Sheath Tumors29. Neuroblastoma30. Soft Tissue Tumors Showing Melanocytic Differentiation31. Osteocartilaginous Soft Tissue Tumors, Tumoral Calcinosis and Amyloidoma32. Myxoid Soft Tissue Tumors: Benign, Borderline and Malignant33. Soft tissue tumors showing epithelial, myoepithelial or notochordal differentiation34. Fusion-defined soft tissue tumors with predominantly round cell morphology35. Other important Malignant Soft Tissue Tumors36. Emerging Entities